Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» CLL
CLL
Infinity Reports Phase 1 Data Showing Clinical Activity of Duvelisib in Treatment-Naïve Patients with Chronic Lymphocytic Leukemia
Yahoo
Sun, 05/31/15 - 11:30 am
Infinity Pharmaceuticals
ASCO
duvelisib
chronic lymphocytic leukemia
CLL
AbbVie, Roche nab FDA breakthrough designation for top leukemia prospect
BioPharma Dive
Fri, 05/8/15 - 11:01 am
AbbVie
Roche
FDA
CLL
chronic lymphocytic leukemia
venetoclax
AbbVie leukemia drug gets breakthrough status
Medical Marketing and Media
Wed, 05/6/15 - 06:59 pm
AbbVie
CLL
chronic lymphocytic leukemia
venetoclax
Imbruvica performs well in high-risk leukemia patients
Seeking Alpha
Mon, 01/5/15 - 04:10 pm
Imbruvica
CLL
chronic lymphocytic leukemia
Pharmacyclics
ASCO '14 Preview: Blood Cancer Data from Pharmacyclics, Gilead, Abbvie
TheStreet.com
Thu, 05/15/14 - 08:29 am
ASCO
Gilead Sciences
AbbVie
Pharmacyclics
Imbruvica
CLL
Idelalisib
mantle cell lymphoma
ABT-199
J&J, Roche, Novartis tout key cancer-drug data at ASH
Fierce Pharma
Mon, 12/9/13 - 10:12 am
JNJ
Roche
Novartis
Imbruvica
Tasigna
CLL
Gazyva
New Leukemia Drugs Bring Chemotherapy-Free Treatment Potential
Bloomberg
Mon, 12/9/13 - 08:38 am
Gilead Sciences
Roche
Pharmacyclics
CLL
chronic lymphocytic leukemia
Ditching Big Drugmakers for Biotech Brings Leukemia Boon
Bloomberg
Thu, 12/5/13 - 08:26 am
chronic lymphocytic leukemia
Gilead
Pharmacyclics
CLL
Roche
Gilead’s Idelalisib Significantly Reduces Rate of Disease Progression or Death in Phase 3 Chronic Lymphocytic Leukemia Study
Yahoo
Mon, 11/18/13 - 10:28 am
Gilead
Idelalisib
CLL
chronic lymphocytic leukemia
Roche's Gazyva Approval Marks Success in Oncology and New FDA Designation
Motley Fool
Tue, 11/5/13 - 03:55 pm
Roche
Gazyva
FDA
CLL
chronic lymphocytic leukemia
FDA approves Roche leukemia drug Gazyva
Reuters
Fri, 11/1/13 - 11:48 am
FDA
Roche
Gazyva
chronic lymphocytic leukemia
CLL
GSK/Genmab file Arzerra for first-line CLL
Pharma Times, UK
Mon, 10/21/13 - 09:56 am
Arzerra
GSK
Genmab
CLL
chronic lymphocytic leukemia
Tiny Biotech Developing Drugs Akin To Biogen's Rituxan Seen As Potential Buyout Bet
Forbes
Mon, 05/27/13 - 08:17 pm
Biogen Idec
Rituxan
TG Therapeutics
Utuxin
TGR-1202
CLL
chronic lymphocytic leukemia
non-Hodgkin's lymphoma
ASCO '13 Preview: Gilead's Big Cancer Debut
TheStreet.com
Thu, 05/16/13 - 08:54 am
Gilead
ASCO
JNJ
Pharmacyclics
idelalisab
ibrutinib
CLL
Pharmacyclics says FDA grants Breakthrough Therapy Designation for ibrutinib
Yahoo/Fly on the Wall
Mon, 04/8/13 - 11:05 am
FDA
Pharmacyclics
ibrutinib
CLL
Emergent Biosolutions to expand clinical trial of TRU-016 and rituximab
Reuters
Fri, 04/5/13 - 11:06 am
Emergent BioSolutions
rituximab
TRU-016
CLL
Pages
« first
‹ previous
1
2
3
4